Sanja Hukovic
Allan Hackshaw
Allan Hackshaw is Professor of Epidemiology & Medical Statistics at University College London, and Director of the Cancer Research UK & UCL Cancer Trials Centre. He has over 30 years’ experience in the design, conduct, analysis and interpretation of cohort/case-control studies, large real-world data studies, phase I-III clinical trials, and systematic reviews; in several areas including cancer, and tobacco and health. His particular focus has been on adult (mainly cancer) and prenatal screening, as a key investigator on large scale studies, some of which have evaluated new screening tests and policies that later became routine practice. He is a member of the UK National Screening Committee Adult Reference Group, and co-editor of the Journal of Medical Screening. He has published more than 200 journal articles and book chapters, and sole or first author of four textbooks.
Darren Hodgson
Darren is Executive Director, Translational Medicine Strategy, Oncology, AstraZeneca having previously had positions in global medicine development, academia, biotechnology, and diagnostics. Darren has over 15 years’ experience as lead or core member of multi-functional global product teams and has been responsible for strategy, internal and external assay development, clinical deployment, and regulatory representation for biomarkers used as for clinical studies in all stages of drug development. Darren currently heads up an initiative to deploy circulating tumor DNA measures to identify patients with early cancers in need of treatment options and accelerate development programs. Darren was previously the translational lead for Lynparza, AstraZeneca’s first in class PARP inhibitor, and is author of numerous reviews, original patents and papers.
Marthe Riewald
Yan Chen
Vicki Plaks
Sylvain Roy
Sumant Ramachandra
Steven Katz
